You searched for Richter's - Page 4 of 4

ASH 2021: A Phase 1a/b Dose Escalation Study of the Mutation Agnostic BTK/FLT3 Inhibitor Luxeptinib (CG-806) in Patients with Relapsed or Refractory B-Cell Malignancies

February 9, 2022

Treatments for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (CLL / SLL) are being developed to address refractory cases, in other words, those that no longer respond to current therapies. In this study presented at the American Society of Hematology Annual Meeting and Exhibition (ASH 2021), the results of early (phase 1a/b) trials on Luxeptinib in 23 patients are reviewed.

Medical Advisory Board

October 14, 2021

CLL Society Medical Advisory Board CLL Society’s Medical Advisory Board is comprised of leading CLL / SLL experts from across the country. Members generously provide their time and talent to the

Clinical Trials

September 13, 2021

CLL Clinical Trials CLL is not a solved problem, but we do have excellent treatments. It was only through clinical trials that the safety and efficacy of existing therapies was proven, and the

CLL Abbreviations & Acronyms

August 31, 2021

Abbreviations & Acronyms In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical

CLL Society Webinar Archive: Global Virtual Patient & Caregiver Educational Forum – Flash Session 1

November 6, 2020

Recorded Saturday, October 10, 2020 Flash Session 1: Richter’s Transformation https://youtu.be/LbrVcvY9Lw4 CLL Society Resources Download Slides Audience Questions Agenda About CLL Society Sign up for CLL Society’s This Week emails

CLL Society Webinar Archive: Global Virtual Patient & Caregiver Educational Forum

October 29, 2020

Recorded Saturday, October 10, 2020 Welcome and Introductions SPEAKERPatricia KoffmanCo-Founder and Communications DirectorCLL Society Click to play Session 1: Definitions, Diagnosis, Test Before Treat™ and Early Management in CLL MODERATORBrian Koffman,

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Search Results for: Richter's – Page 4

ASH 2021: A Phase 1a/b Dose Escalation Study of the Mutation Agnostic BTK/FLT3 Inhibitor Luxeptinib (CG-806) in Patients with Relapsed or Refractory B-Cell Malignancies

Medical Advisory Board

Clinical Trials

CLL Abbreviations & Acronyms

CLL Society Webinar Archive: Global Virtual Patient & Caregiver Educational Forum – Flash Session 1

CLL Society Webinar Archive: Global Virtual Patient & Caregiver Educational Forum

Michelle’s Story

CT Scans & Secondary Cancers

CT Scans

Didn't find what you where looking for?

Smart Patients
Get Smart Care™

Smart Patients Get Smart Care™

ABOUT US

CONNECT